Integrated DNA Technologies Celebrates Grand Opening of Flagship European Facility
News Sep 24, 2008
Integrated DNA Technologies (IDT) has celebrated the grand opening of its flagship European facility in Haasrode Research Park, Leuven, Belgium.
According to Company, the 2000 m2 research and production site enables IDT to serve customers throughout Europe, the Middle-East, and Africa with the same speed and quality that have made IDT the industry leader in the United States.
Dr. Joseph A. Walder, IDT’s founder and CEO, led the grand opening event. He emphasized that Europe is IDT’s most important market outside North America, and that IDT has invested in the heart of Europe as part of its long-range strategy to serve the research community globally.
“Although our origins are in the U.S., IDT is now just as much a European company as we are an American one,” Dr. Walder stressed.
“We want researchers in Europe to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis,” Dr. Walder continued, “and we want to learn from our European colleagues how IDT can best support their research as the science and application of synthetic biology advances.”
Joining IDT and its many guests was the Mayor of Leuven, Louis Tobback, who expressed his gratitude for IDT’s commitment to Europe and to Belgium. Thanking Dr. Walder in particular, he spoke on behalf of his city and region: “It is an honour that IDT has chosen Leuven for its primary European operation, and we are confident that IDT’s investment will benefit Belgium, IDT, and scientists throughout Europe.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.